Vitalhub (TSE:VHI) Given a C$14.00 Price Target at Scotiabank

Scotiabank set a C$14.00 target price on Vitalhub (TSE:VHI) in a report issued on Thursday morning,BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.

Several other research firms have also weighed in on VHI. TD Securities upgraded shares of Vitalhub to a “strong-buy” rating in a report on Monday, November 25th. Canaccord Genuity Group increased their price objective on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Finally, Cormark lifted their target price on Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research report on Wednesday, October 2nd. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of C$10.71.

Vitalhub Stock Up 2.9 %

Shares of TSE:VHI opened at C$11.81 on Thursday. Vitalhub has a 52-week low of C$4.36 and a 52-week high of C$12.09. The business has a fifty day moving average of C$11.29 and a two-hundred day moving average of C$9.66. The stock has a market cap of C$600.54 million, a P/E ratio of 107.36, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.